G6PD deficiency triggers dopamine loss and the initiation of Parkinson's disease pathogenesis: Cell Reports Glutathione S transferase: A keystone in Parkinson's disease pathogenesis and therapy ScienceDirect Targeting the Cysteine Redox Proteome in Parkinson's Disease: The Role of Glutathione Precursors and Beyond Is it time to back NAC? The Science of Parkinson's How Glutathione (GSH) May Help Reduce Parkinson's Symptoms Cardiology & Neurology Specialists located in Queens, Forest Hills and Brighton Beach, Brooklyn, NY Advanced Medical Care Targeting ferroptosis with the lipoxygenase inhibitor PTC 041 as a therapeutic strategy for the treatment of Parkinson's disease PLOS One